LITS logo
LITS NASDAQ US

Lite Strategy, Inc. - Common Stock

Healthcare · Biotechnology Website · IPO Dec 2003
$1.12
▼ $-0.01 (-0.89%)
Vol 219K
5
Quality Score
fail
Mkt Cap
$48.6M
ROE
-76.4%
Margin
39.1%
D/E
0.00
Beta
1.31
52W
$1–$3

Wall Street Consensus

6 analysts · Nov 2025
0
Strong Buy
0
Buy
3
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating

Price Chart

Similar Stocks

LSTA
Lisata Therapeutics Inc
$16.4M
ESLA
Estrella Immunopharma Inc
$58.9M
RLYB
Rallybio Corp
$29.0M
ALGS
Aligos Therapeutics Inc
$57.4M
ATRA
Atara Biotherapeutics Inc
P/E 5.6
$130.4M
SNSE
Sensei Biotherapeutics Inc
$13.5M
CELU
Celularity Inc
$31.6M
CRVO
CervoMed Inc
$73.1M
NXTC
NextCure Inc
$49.7M

Earnings

Beat rate: 50.0%
Next Report May 11, 2026
Quarter EPS Est EPS Act Surprise
Sep 2026 — — —
Jun 2024 $-1.46 $-2.76 $-1.30
Mar 2024 $-1.55 $-1.37 +$0.18
Dec 2023 $-1.35 $-1.66 $-0.31

Fundamentals Trend

Metric 2025-03-31 2025-06-30 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -127.2% -76.4% -127.2% -76.4% -76.4% -76.4%
P/E (TTM) — — — — — —
Net Margin — — 39.0% 39.0% 39.0% 39.0%
Gross Margin — — 100.0% 100.0% 100.0% 100.0%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 16.78 13.50 16.78 13.50 13.50 12.39

Key Ratios

ROA (TTM)
-69.9%
P/S (TTM)
0.46
EPS (TTM)
$-2.39
52W High
$3.23
52W Low
$1.30
$1.30 52-Week Range $3.23

How does LITS compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

LITS AAPG ABEO ABOS ABP

LITS valuation vs Biotechnology peers

P/E ratio
—
▼ 0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
0.5
▼ 96% below peers (12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼ 0% below peers (2.5)
vs Peers
vs Industry
Overvalued
Div yield
—
▼ 0% below peers (0.0%)
vs Peers
vs Industry
Low yield

LITS profitability vs Biotechnology peers

ROE
-76.4%
▼ 14% below peers (-67.3%)
vs Peers
vs Industry
In line
Net margin
39.1%
▲ 114% above peers (-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
100.0%
▲ 27% above peers (78.6%)
vs Peers
vs Industry
Weak
ROA
-69.9%
▼ 50% below peers (-46.7%)
vs Peers
vs Industry
Weak

LITS financial health vs Biotechnology peers

D/E ratio
0.0
▼ 0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
12.4
▲ 179% above peers (4.4)
vs Peers
vs Industry
Strong liquidity
Beta
1.3
▲ 35% above peers (1.0)
vs Peers
vs Industry
More volatile

LITS fundamentals radar

LITS Peer median Industry

LITS profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

LITS vs peers: key metrics

Latest News

No related news yet